Immune elimination of Leishmania major in mice: Implications for immune memory, vaccination, and reactivation disease

Journal of Immunology

Volumn 167, Issue 12, 2001, Pages 6967-6974

  Uzonna, J E ^a   Wei, G ^a   Yurkowski, D ^a   Bretscher, P ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HOST PARASITE INTERACTION; HOST SUSCEPTIBILITY; IMMUNOLOGICAL MEMORY; IMMUNOREACTIVITY; IMMUNOREGULATION; INFECTION RESISTANCE; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; VACCINATION;

EID: 0035893005     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.12.6967     Document Type: Article

References (47)

1. Leishmaniasis
2. Immunology of leishmaniasis
3. Helper T cell subsets in mouse leishmaniasis: Induction, expansion and effector function
4. Th cell development and regulation in experimental cutaneous leishmaniasis
5. Experimental cutaneous leishmaniasis: Induction and regulation of T cells following infection of mice with Leishmania major
6. Establishment of stable, cell-mediated immunity that makes 'susceptible' mice resistance to Leishmania major
7. Characterization of the immunological memory state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge
8. Parasite dose determines the Th1/Th2 nature of the response to L major independently of infection route, strain of host or parasite
9. Systemic infection of Leishmania tropica (major) in various strains of mice
10. Analysis of the cellular parameters of the immune response contributing to resistance and susceptibility of mice to infection with intracellular parasite
11. Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: A possible hazard for the host
12. The regulation of immunity to Leishmania major
13. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase
14. The host response to leishmania infection
15. Vaccination against cutaneous leishmaniasis in murine model I. Induction of protective immunity with soluble extract of promastigotes
16. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice
17. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerised ovalbumin: Directed induction of T-helper type-1-Iike activation
18. Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells
19. A valid ELISPOT assay for enumeration of ex vivo, antigen-specific fFN-γ-producing cells
20. Immunological memory
21. From naive to memory T cells
22. Distinct regulation of lymphokine production is found in fresh versus in vitro primed murine helper cells
23. Immune mechanisms underlying the premunition against Plasmodium falciparium
24. Mechanisms of defense against P. Falciparium asexual blood stage in humans
25. Immunoregulation of malarial infection: Balancing the vices and virtues
26. IL-12 is required to maintain a Th1 response during L. major infection
27. The role of IL-12 in the maintenance of an established Th1 immune response in experimental leishmaniasis
28. The role of antigen and IL-12 in sustaining Thl memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite
29. Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major
30. Role of T cell subsets during the recall of immunologic memory to Leishmania major
31. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
32. On immunological memory
33. Factors controlling the turnover of T memory cells
34. Cellular immunity
35. T cell memory is short-lived in the absence of antigen
36. Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen
37. Induction of long-lived germinal centers associated with persisting antigen after viral infection
38. On the cellular basis of immunological T cell memory
39. T cell memory
40. Selecting and maintaining a diverse T-cell repertoire
41. Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation
42. Homeostatic T cell proliferation. How far can T cells be activated against self-ligands?
43. Leishmania-HIV interaction: Immunopathogenic mechanisms
44. + T-lymphocyte counts
45. A strategy to improve the efficacy of vaccination against tuberculosis and leprosy
46. Quantitative considerations in the design of vaccination strategies against pathogens uniquely susceptible to cell-mediated attack
47. Towards a strategy of universally efficacious vaccination against pathogens uniquely susceptible to cellmediated attack